Paediatric palliative care in the Asia Pacific region: where are we now?

Poh Heng Chong1, Ednin Hamsah2, Cynthia Goh3

  • 1Star PALS, HCA Hospice Care, Singapore.

Insights

Paediatric palliative care services are growing globally. A survey of Asia Pacific professionals revealed diverse service models and identified key training needs in bereavement and spiritual care, alongside a concerning lack of paediatrician support.

Area of Science:

  • Palliative Care
  • Paediatric Medicine
  • Healthcare Services Research

Background:

  • Increasing global demand for paediatric palliative care (PPC) services for children with life-limiting conditions.
  • Need for service mapping within the Asia Pacific Hospice Network for collaboration, education, and advocacy.
  • Emergence of a special interest group to address PPC challenges.

Purpose of the Study:

  • To map existing PPC services in the Asia Pacific region.
  • To document current service provision, training needs, and practice challenges.
  • To identify common struggles and needs across diverse PPC services.

Main Methods:

  • Online survey conducted over 2 months among regional professionals.
  • Questionnaire developed through consensus by a special interest group.
  • Data collected from 59 responses across 16 countries, including content analysis of narrative responses.

Main Results:

  • 59 distinct PPC services identified across 16 countries; directory created and circulated.
  • Half of services cater to both adults and children, with varied staffing and funding models.
  • Highest training needs identified in bereavement and spiritual care; significant lack of paediatrician support noted.

Conclusions:

  • PPC services in the Asia Pacific region exhibit heterogeneity in models and provision but share common challenges.
  • Addressing training needs in bereavement, spiritual care, and enhancing paediatrician support are crucial.
  • Service profiling can foster a common vision and facilitate expertise sharing for improved PPC.

Related Concept Videos

Continuing Care01:25

Continuing Care

Continuing care describes the variety of health, personal, and social services provided over a prolonged period. The need for continuing care is increasing because people are living longer. Many people do not have families or others to care for them. Continuing care is mainly for patients who are disabled, functionally dependent, or suffering from a terminal disease. It is available within institutional settings or in homes. Examples include nursing centers or facilities, assisted living,...
2.1K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
337
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
750
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
377
Primary Healthcare Services01:30

Primary Healthcare Services

Primary care promotes wellness and prevents disease. This care includes health promotion, education, protection (such as immunizations), early disease screening, and environmental considerations. Settings providing this type of healthcare include physician offices, public health clinics, school nursing, and community health nursing.
In 1978, international leaders convened in Alma-Ata, Kazakhstan, for what would be a pivotal event in global health. The Alma-Ata Declaration was the first to call...
2.7K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
482